Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations.

Nature communications·2026

Same author

Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder.

The Journal of pathology·2026

Same author

Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis.

Journal of proteome research·2026

Same author

Dichotomous role of CD47-SIRP<i>α</i> axis: Leveraging opposing functions in phagocytic resistance and transport assistance for enhanced nanocarrier biocompatibility and tumor penetration.

Acta pharmaceutica Sinica. B·2026

Same author

Long-term survival and the critical role of competing risks in pneumoconiosis: a large-scale retrospective cohort study.

Frontiers in public health·2026

Same author

Targeting Ferroptosis in Sensorineural Hearing Loss: A Mechanistic Review of Therapeutic Opportunities.

Current issues in molecular biology·2025

Same journal

Deferoxamine-coated mesoporous silica nanoparticles sustainably reduce iron overload in HepG2 cells. A protein corona study on plasma from hemochromatotic mice.

Drug delivery and translational research·2026

Same journal

Optimizing snake fang-inspired microneedles for transdermal liquid drug delivery.

Drug delivery and translational research·2026

Same journal

Radiopaque microsphere-hydrogel composite for extended-release intratumoral immunotherapy in a large animal model.

Drug delivery and translational research·2026

Same journal

Redispersible nanoalum-adjuvanted hepatitis B vaccine microneedles with enhanced immunogenicity.

Drug delivery and translational research·2026

Same journal

Mannose receptor-targeted MSC-derived exosomes as a high-affinity delivery platform for liver sinusoidal endothelial cells.

Drug delivery and translational research·2026

Same journal

Oral nanoparticle-encapsulated enzyme replacement therapy for mucopolysaccharidosis type I (MPS-I): a proof of concept study.

Drug delivery and translational research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 25, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Advances in constructing biocompatible nanocarriers.

Xuehui Duan¹, Xinlei Chu¹, Yan Du¹

¹School of Pharmaceutical Sciences & Institute of Materia Medica, Medical Science and Technology Innovation Center, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.

Drug Delivery and Translational Research

|June 18, 2025

Summary

This summary is machine-generated.

Designing biocompatible nanocarriers is crucial for drug delivery success. This review analyzes inert materials, polymer engineering, and biomimetic methods to optimize nanocarrier safety and efficacy for clinical translation.

Keywords:

Biocompatibility Biomimetic strategies Inert carriers Nanocarriers Polymer modification

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Related Experiment Videos

Last Updated: May 25, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Area of Science:

Biomaterials Science
Nanotechnology
Drug Delivery

Background:

Effective drug nanocarriers must minimize adverse biological interactions like immune activation and cytotoxicity.
Superior biocompatibility is essential for the clinical success of nanomedicines.
Existing reviews often focus on therapeutic applications, with limited systematic analysis of biocompatibility optimization.

Purpose of the Study:

To systematically review and analyze strategies for enhancing nanocarrier biocompatibility.
To provide guidance on selecting optimal methods for biocompatibility enhancement in nanomedicine.
To bridge the gap in literature regarding biocompatibility optimization for nanocarrier design.

Main Methods:

Review of three primary approaches: inert-material-based frameworks, polymer surface engineering, and biomimetic functionalization.
Evaluation of structural designs and biological mechanisms of commonly used materials.
Analysis of advantages and limitations of each biocompatibility enhancement strategy.

Main Results:

Identified three key strategies for constructing biocompatible nanocarriers.
Elucidated how these strategies utilize material properties and biological interactions to regulate biocompatibility.
Provided a comparative analysis of the strengths and weaknesses of each approach.

Conclusions:

Synthesized current advancements in biocompatible nanocarrier development.
Offered actionable insights for improving nanomedicine research and clinical translation.
Highlighted the importance of strategic biocompatibility optimization for nanocarrier design.